Crinetics Pharmaceuticals Inc (CRNX) Insider Trading
- $45,793,090.74
- $62,774,813.12
- April 15, 2024
- Stephen F Betz
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 15, 2024 | Insider | 14,375 | $44.47 | Sell | $639,256.25 | |
April 4, 2024 | CEO | 40,951 | $49.17 | Sell | $2,013,560.67 | |
March 28, 2024 | Director | 17,500 | $46.38 | Sell | $811,650.00 | |
March 22, 2024 | COO | 32,359 | $44.31 | Sell | $1,433,827.29 | |
March 20, 2024 | Insider | 15,089 | $44.06 | Sell | $664,821.34 | |
March 20, 2024 | Director | 60,000 | $44.14 | Sell | $2,648,400.00 | |
March 19, 2024 | CFO | 6,942 | $42.91 | Sell | $297,881.22 | |
Jan. 25, 2024 | Insider | 3,000 | $37.26 | Sell | $111,780.00 | |
Jan. 10, 2024 | Insider | 3,000 | $37.65 | Sell | $112,950.00 | |
Jan. 3, 2024 | Insider | 14,375 | $35.00 | Sell | $503,125.00 | |
Jan. 2, 2024 | CFO | 10,000 | $35.47 | Sell | $354,700.00 | |
Dec. 26, 2023 | Insider | 3,000 | $35.89 | Sell | $107,670.00 | |
Dec. 21, 2023 | Insider | 9,583 | $34.57 | Sell | $331,284.31 | |
Dec. 11, 2023 | Insider | 3,000 | $32.87 | Sell | $98,610.00 | |
Nov. 27, 2023 | Insider | 3,000 | $31.84 | Sell | $95,520.00 | |
Nov. 3, 2023 | CEO | 199,082 | $30.56 | Sell | $6,083,945.92 | |
Nov. 1, 2023 | CFO | 10,000 | $28.75 | Sell | $287,500.00 | |
Oct. 17, 2023 | Insider | 7,000 | $30.00 | Sell | $210,000.00 | |
July 13, 2023 | CEO | 14,157 | $20.35 | Sell | $288,094.95 | |
July 11, 2023 | CEO | 24,384 | $20.14 | Sell | $491,093.76 | |
June 20, 2023 | CFO | 30,922 | $19.97 | Sell | $617,512.34 | |
June 16, 2023 | CEO | 50,000 | $20.81 | Sell | $1,040,500.00 | |
June 8, 2023 | Director | 5,000 | $22.06 | Buy | $110,300.00 | |
April 5, 2023 | Insider | 8,212 | $16.15 | Sell | $132,623.80 | |
Jan. 25, 2023 | Insider | 8,336 | $21.07 | Sell | $175,639.52 | |
Jan. 17, 2023 | Insider | 3,126 | $18.00 | Sell | $56,268.00 | |
Dec. 15, 2022 | Insider | 3,126 | $16.00 | Sell | $50,016.00 | |
Dec. 1, 2022 | Insider | 3,126 | $17.84 | Sell | $55,767.84 | |
Nov. 15, 2022 | Insider | 3,126 | $18.72 | Sell | $58,518.72 | |
Oct. 17, 2022 | Insider | 3,126 | $17.73 | Sell | $55,423.98 | |
Oct. 3, 2022 | Insider | 3,126 | $19.64 | Sell | $61,394.64 | |
Sept. 15, 2022 | Insider | 4,168 | $21.01 | Sell | $87,569.68 | |
Sept. 7, 2022 | Insider | 1,042 | $21.00 | Sell | $21,882.00 | |
July 26, 2022 | COO | 1,152 | $20.70 | Sell | $23,846.40 | |
July 13, 2022 | N/A | 5,700 | $20.96 | Sell | $119,472.00 | |
July 13, 2022 | Director | 5,700 | $20.96 | Sell | $119,472.00 | |
May 2, 2022 | Insider | 3,247 | $20.10 | Sell | $65,264.70 | |
April 18, 2022 | Major Shareholder | 157,515 | $22.22 | Buy | $3,499,983.30 | |
April 18, 2022 | Insider | 5,664 | $25.81 | Sell | $146,187.84 | |
April 13, 2022 | CEO | 138,643 | $26.83 | Sell | $3,719,791.69 | |
April 5, 2022 | CEO | 21,357 | $25.34 | Sell | $541,186.38 | |
April 4, 2022 | Insider | 9,000 | $23.97 | Sell | $215,730.00 | |
March 31, 2022 | Insider | 4,164 | $21.06 | Sell | $87,693.84 | |
March 1, 2022 | Insider | 3,123 | $19.73 | Sell | $61,616.79 | |
Feb. 7, 2022 | Insider | 13,411 | $17.83 | Sell | $239,118.13 | |
Feb. 1, 2022 | Insider | 3,123 | $18.79 | Sell | $58,681.17 | |
Jan. 18, 2022 | Insider | 4,168 | $23.29 | Sell | $97,072.72 | |
Jan. 3, 2022 | Insider | 7,168 | $28.02 | Sell | $200,847.36 | |
Dec. 28, 2021 | Insider | 3,000 | $27.95 | Sell | $83,850.00 | |
Dec. 15, 2021 | Insider | 5,668 | $24.14 | Sell | $136,825.52 |
Insiders are both buying and selling Crinetics Pharmaceuticals Inc stock.
The insider traders at Crinetics Pharmaceuticals Inc are: Stephen F Betz, Vivo Capital Viii, Llc, Richard Scott Struthers, Matthew K Fust, Dana Pizzuti, Marc Wilson, Perceptive Advisors Llc, Ventures Iv L.P. 5Am, Alan Seth Krasner, Jeff E Knight, Ajay Madan, Stephanie Okey, Coelho Rogerio Vivaldi, Life Sciences Maste Perceptive, Vivo Capital Fund Viii, L.P., and Fust Matthew K
The most active insider trader at Crinetics Pharmaceuticals Inc is Stephen F Betz with 30 trades.
Ventures Iv L.P. 5Am has sold the most Crinetics Pharmaceuticals Inc stock with a total value of $20,590,753.39.
Perceptive Advisors Llc has bought the most Crinetics Pharmaceuticals Inc stock with a total value of $35,759,962.44.
The most recent insider trade for Crinetics Pharmaceuticals Inc was on April 15, 2024.
The single biggest insider buy for Crinetics Pharmaceuticals Inc was from Perceptive Advisors Llc with a total value of $23,760,000.00 on Oct. 25, 2021.
The single biggest insider sell for Crinetics Pharmaceuticals Inc was from Vivo Capital Fund Viii, L.P. with a total value of $9,278,250.00 on March 20, 2019.